Published by mark itwired
Posted on September 28, 2021
6 min readLast updated: February 1, 2026
The Molecular Imaging Market is set to grow at an 11.3% CAGR from 2021 to 2031, driven by advancements in diagnostic technology and rising cancer cases.
Molecular imaging is an emerging diagnostic technology that allows visualization, differentiation, and quantify various biological processes occurring inside a living organism at the molecular and cellular level. The global molecular imaging market is estimated to be valued approximately at US$ 4 Bn in 2021, finds Future Market Insights (FMI) in a study.
Molecular imaging targets molecular pathways and mechanisms associated with a particular disease present inside a living body. It enables to study of the molecular abnormalities taking place inside the body to carry out early detection of disease and to optimize medications aiming for disease-related molecular targets. Nuclear medicine plays a vital role in conducting a molecular imaging process and can be broadly used for the treatment of distinct cancer and related diseases.
Clinical molecular imaging is trending towards hybrid modalities such as PET-CT, SPECT, or PET-MR that provide high-resolution anatomical imaging. PET-CT is anticipated to gain maximum revenue share over the forecast period, and the segment is projected to expand at a CAGR of 16.3% during the forecast period.
Molecular imaging has evolved as a promising tool for early detection of cancers and cardiac diseases, providing a more complete picture of the tumor genome, as well as monitoring tumor emergence during disease. Molecular imaging provides the ability to accurately evaluate biological responses to the treatment of individual patients over time, opening the door to personalized medical techniques directed by molecular imaging reporters.
Request For Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-724
“Increasing research & development activities in cancer-specific drug discovery and other chronic diseases are expected to boost demand for molecular imaging. Besides this, as a result of increasing incidence of cancer the demand for highly sensitive and precise diagnostic for better treatment solutions is increasing,” says a Future Market Insights analyst.
According to the World Health Organization (WHO) in 2020, breast cancer emerged as the most common type of cancer, affecting 2.2 million people around the world. Lung cancer has been the leading cause of death with over 1.7 Mn of total deaths in 2020. North America has the highest incidence rate of cancer followed by East Asia. This rise in the cancer population is leading to a rise in the demand for diagnostic imaging, thereby catalyzing the demand for molecular imaging.
Key players in the molecular imaging market are keenly focusing on carrying out strategic activities such as acquisitions, collaborations, and mergers, product launch, global expansion to create a strong position in the market is leading to vigorous developments which are helping the market to grow at a considerable rate.
Strategies adopted by key players are often intended at global expansion. They largely focus on product launches and mergers & acquisitions. There have been a few strategic partnerships among leading players to enhance the product line and better facilities for end-user.
Some of the key players are Key market players covered by Future Market Insights in the report are is Hermes Medical Solutions, Bruker Corporation, GE Company, Fujifilm Holdings Corp., Koninklijke Philips N.V., Siemens AG, Toshiba Medical System Corp., Mirada Medical Limited, Carestream Health, Inc., Esaote SpA, Positron Corporation, Medisco Ltd., Hitachi Medical Corp., MIM Software Inc.
Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global molecular imaging market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights based on a modality (Positron Emission Tomography (PET), Positron Emission Tomography- Computed Tomography (PET-CT), Positron Emission Tomography- Magnetic Resonance (PET-MR), Single Photon Emission Computed Tomography (SPECT), Software, Magnetic Resonance Spectroscopy, Molecular Ultrasound Imaging), Application (Cardiology, Oncology, Gastrointestinal Disorders, Neurology Disorders, Others) and end-user ( Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), across seven major regions of the world.
Any Queries, Contact Us @ https://www.futuremarketinsights.com/ask-question/rep-gb-724
North America has the highest market share in the global molecular imaging market. Increasing pool of cancer patient along with a large number of R&D centres is creating high growth opportunities within the region. The U.S. currently leads the global market.
PET-CT is expected to be the most lucrative among the modality, with increasing demand for highly sensitive and high-precision diagnostic techniques. The segment is expected to continue to expand at a CAGR of more than 16% over the forecast period.
Some of the leading companies in this landscape are Bruker Corporation, GE Company, Fujifilm Holdings Corp., Koninklijke Philips N.V., Siemens AG, and Toshiba Medical System Corp.
Oncology is expected to dominate the market over the forecast period, generating revenue of 4703.8 Mn by 2031. On the other hand, research will experience significant growth at a CAGR of approximately 11.2% through 2031.
Hospitals are expected to dominate the market as leading end users between 2021 and 2031.
The post Molecular Imaging Market will expand at an impressive CAGR of around 11.3% from 2021 to 2031 first appeared on Market Research Blog.
The article discusses the growth and trends in the Molecular Imaging Market, highlighting its projected expansion and technological advancements.
The market growth is driven by advancements in diagnostic technology, increasing cancer cases, and the adoption of personalized medicine.
Key trends include the rise of hybrid imaging modalities like PET-CT and the focus on personalized medical techniques.
Explore more articles in the Research Reports category
